CD371 cell surface expression: a unique feature of -rearranged acute lymphoblastic leukemia.
作者信息
Schinnerl Dagmar, Mejstrikova Ester, Schumich Angela, Zaliova Marketa, Fortschegger Klaus, Nebral Karin, Attarbaschi Andishe, Fiser Karel, Kauer Maximilian O, Popitsch Niko, Haslinger Sabrina, Inthal Andrea, Buldini Barbara, Basso Giuseppe, Bourquin Jean-Pierre, Gaipa Giuseppe, Brüggemann Monika, Feuerstein Tamar, Maurer-Granofszky Margarita, Panzer-Grümayer Renate, Trka Jan, Mann Georg, Haas Oskar A, Hrusak Ondrej, Dworzak Michael N, Strehl Sabine
机构信息
CCRI, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.
CLIP - Childhood Leukemia Investigation Prague, Prague, Czech Republic.
出版信息
Haematologica. 2019 Aug;104(8):e352-e355. doi: 10.3324/haematol.2018.214353. Epub 2019 Jan 31.
Abstract
摘要
相似文献
1
CD371 cell surface expression: a unique feature of -rearranged acute lymphoblastic leukemia.
Haematologica. 2019 Aug;104(8):e352-e355. doi: 10.3324/haematol.2018.214353. Epub 2019 Jan 31.
2
Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.
Haematologica. 2013 Jun;98(6):937-44. doi: 10.3324/haematol.2012.067983. Epub 2013 Feb 12.
3
deletions in childhood acute lymphoblastic leukemia with rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity.
Haematologica. 2019 Jul;104(7):1407-1416. doi: 10.3324/haematol.2018.204487. Epub 2019 Jan 10.
4
Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.
Nat Genet. 2016 Dec;48(12):1481-1489. doi: 10.1038/ng.3691. Epub 2016 Oct 24.
5
Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.
Haematologica. 2010 Oct;95(10):1675-82. doi: 10.3324/haematol.2010.023481. Epub 2010 May 21.
6
MEF2D-rearranged acute lymphoblastic leukemia resembles Burkitt lymphoma/leukemia.
Ann Hematol. 2020 Jan;99(1):185-188. doi: 10.1007/s00277-019-03857-x. Epub 2019 Nov 28.
7
Frequent co-expression of HoxA9 and Meis1 genes in infant acute lymphoblastic leukaemia with MLL rearrangement.
Br J Haematol. 2002 Oct;119(1):119-21. doi: 10.1046/j.1365-2141.2002.03803.x.
8
Expression of NG2 antigen in MLL-rearranged acute leukemias: how complex does it get?
Leuk Res. 2011 Aug;35(8):989-90. doi: 10.1016/j.leukres.2011.03.015. Epub 2011 Apr 13.
9
N-terminus DUX4-immunohistochemistry is a reliable methodology for the diagnosis of DUX4-fused B-lymphoblastic leukemia/lymphoma (N-terminus DUX4 IHC for DUX4-fused B-ALL).
Genes Chromosomes Cancer. 2022 Aug;61(8):449-458. doi: 10.1002/gcc.23033. Epub 2022 Mar 7.
10
Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
Semin Diagn Pathol. 2023 May;40(3):202-215. doi: 10.1053/j.semdp.2023.04.003. Epub 2023 Apr 9.
引用本文的文献
1
DUX4-rearranged B-ALL: deciphering a biological and clinical conundrum.
Leukemia. 2025 Sep 12. doi: 10.1038/s41375-025-02758-5.
2
Rapid Identification of Fusion in Acute Lymphoblastic Leukemia.
EJHaem. 2025 Jul 28;6(4):e70099. doi: 10.1002/jha2.70099. eCollection 2025 Aug.
3
C-type lectin-like molecule-1 as a diagnostic, prognostic, and therapeutic marker in leukemia.
Mol Biol Rep. 2025 May 16;52(1):464. doi: 10.1007/s11033-025-10527-x.
4
Effective Utilization of a Customized Targeted Hybrid Capture RNA Sequencing in the Routine Molecular Categorization of Adolescent and Adult B-Lineage Acute Lymphoblastic Leukemia: A Real-World Experience.
Mol Diagn Ther. 2025 May;29(3):407-418. doi: 10.1007/s40291-025-00779-5. Epub 2025 Apr 5.
5
Identification of Rearrangements Using RNA-sequencing in a Patient with ALL: A Case Report.
Ann Lab Med. 2025 May 1;45(3):339-342. doi: 10.3343/alm.2024.0622. Epub 2025 Apr 3.
6
RNA-sequencing: A reliable tool to unveil transcriptional landscape of paediatric B-other acute lymphoblastic leukaemia.
Br J Haematol. 2025 May;206(5):1355-1365. doi: 10.1111/bjh.20056. Epub 2025 Mar 30.
7
Unveiling the potential of CLL-1: a promising target for AML therapy.
Biomark Res. 2025 Feb 12;13(1):28. doi: 10.1186/s40364-025-00738-6.
8
CD36 cell surface expression as a surrogate marker to identify ABL/JAK-class kinase fusions in pediatric BCP-ALL.
Leukemia. 2025 Jan;39(1):64-74. doi: 10.1038/s41375-024-02421-5. Epub 2024 Oct 17.
9
Risk factors in DUX4-positive childhood and adolescent B-cell acute lymphoblastic leukemia.
Blood Cancer J. 2024 Jul 22;14(1):119. doi: 10.1038/s41408-024-01099-3.
10
Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases.
Blood. 2024 Sep 26;144(13):1399-1411. doi: 10.1182/blood.2023021705.
本文引用的文献
1
Advances in B-cell Precursor Acute Lymphoblastic Leukemia Genomics.
Hemasphere. 2018 Jun 20;2(4):e53. doi: 10.1097/HS9.0000000000000053. eCollection 2018 Aug.
2
Prognostic and therapeutic role of CLEC12A in acute myeloid leukemia.
Blood Rev. 2019 Mar;34:26-33. doi: 10.1016/j.blre.2018.10.003. Epub 2018 Nov 1.
3
IKZF1 Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.
J Clin Oncol. 2018 Apr 20;36(12):1240-1249. doi: 10.1200/JCO.2017.74.3617. Epub 2018 Mar 2.
4
Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia.
J Clin Oncol. 2018 Jan 1;36(1):34-43. doi: 10.1200/JCO.2017.74.0449. Epub 2017 Nov 13.
5
Genetic Basis of Acute Lymphoblastic Leukemia.
J Clin Oncol. 2017 Mar 20;35(9):975-983. doi: 10.1200/JCO.2016.70.7836. Epub 2017 Feb 13.
6
AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia.
Cytometry B Clin Cytom. 2018 Jan;94(1):82-93. doi: 10.1002/cyto.b.21518. Epub 2017 Feb 21.
7
Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.
Nat Genet. 2016 Dec;48(12):1481-1489. doi: 10.1038/ng.3691. Epub 2016 Oct 24.
8
Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia.
Nat Commun. 2016 Jun 6;7:11790. doi: 10.1038/ncomms11790.
9
Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.
Nat Genet. 2016 May;48(5):569-74. doi: 10.1038/ng.3535. Epub 2016 Mar 28.
10
CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage.
Leukemia. 2014 Mar;28(3):609-20. doi: 10.1038/leu.2013.354. Epub 2013 Nov 25.
Zotero 插件